Two amino acid differences in the sixth transmembrane domain are partially responsible for the pharmacological differences between the 5- HT(1Dβ) and 5-HT(1E) 5-hydroxytryptamine receptors

Journal of Neurochemistry

Volumn 67, Issue 5, 1996, Pages 2096-2103

  Parker, Eric M ^a,b   Izzarelli, Darcy G ^a   Lewis Higgins, Lore ^a   Palmer, Dawn ^a   Shapiro, Robert A ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

5 HT(1D) receptor; 5 HT(1E) receptor; 5 Hydroxytryptamine; Mutagenesis; Receptor; Serotonin

Indexed keywords

RECEPTOR SUBTYPE; SEROTONIN 1 RECEPTOR; SEROTONIN 1D RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; LIGAND BINDING; MUTAGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN STRUCTURE; RECEPTOR AFFINITY; SEQUENCE ANALYSIS;

EID: 0029822391     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67052096.x     Document Type: Article

References (29)

1. 1 receptor subtype coupled to the inhibition of adenylate cyclase. Proc. Natl. Acad. Sci. USA 90, 408-412.
2. Anderson S., Davis D. L., Dahlback H., Jornvall H., and Russell D. W. (1989) Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J. Biol. Chem. 264, 8222-8229.
3. Baldwin J. M. (1994) Structure and function of receptors coupled to G proteins. Curr. Opin. Cell Biol. 6, 180-190.
4. Boess F. G. and Martin I. L. (1994) Molecular biology of 5-HT receptors. Neuropharmacology 33, 275-317.
5. Ic serotonin receptors. Mol. Pharmacol. 42, 627-633.
6. 2-adrenergic receptors. Proc. Natl. Acad. Sci. USA 85, 9494-9498.
7. Gather U., Nilsson L., Lowe J. A., and Schwartz T. W. (1994) Two specific residues at the top of transmembrane segment V and VI of the neurokinin-1 receptor involved in binding of the non-peptide antagonist CP-96,345. J. Biol. Chem. 269, 23959-23964.
8. 3H]5-hydroxytryptamine binding site subtype in bovine brain membranes. J. Neurosci. 7, 894-903.
9. Hoyer D., Clarke D. E., Fozard J. R., Hartig P. R., Martin G. R., Mylecharane E. J., Saxena P. R., and Humphrey P. P. A. (1994) VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46, 157-203.
10. 2adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science 240, 1310-1316.
11. 1E) in human brain: interaction with a GTP-binding protein. J. Neurochem. 53, 465-471.
12. MacKenzie R. G., Steffey M. E., Manelli A. M., Pollock N. J., and Frail D. E. (1993) A D1/D2 chimeric dopamine receptor mediates a D1 response to a D2-selective agonist. FEBS Lett. 323, 59-62.
13. 5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization. Mol. Pharmacol. 43, 313-319.
14. McAllister G., Charlesworth A., Snodin C., Beer M. S., Noble A. J., Middlemiss D. N., Iversen L. L., and Whiting P. (1992) Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtype. Proc. Natl. Acad. Sci. USA 89, 5517-5521.
15. Munson P. J. and Rodbard D. (1980) LIGAND: a versatile computerized approach for the characterization of ligand binding systems. Anal. Biochem. 107, 220-239.
16. 1B receptors. J. Neurochem. 60, 380-383.
17. 1 receptors expressed in Sf9 insect cells. Eur. J. Pharmacol. Mol. Pharmacol. 268, 43-53.
18. Plassat J.-L., Boschert U., Amlaiky N., and Hen R. (1992) The mouse 5HT5 receptor reveals a remarkable heterogeneity within the 5HT1D receptor family. EMBO J. 11, 4779-4786.
19. Plassat J.-L., Amlaiky N., and Hen R. (1993) Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Mol. Pharmacol. 44, 229-236.
20. Sambrook J., Fritsch E. F., and Maniatis T. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
21. Sanger F., Nicklen S., and Coulsen A. R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
22. Schwartz T. W. (1994) Locating ligand-binding sites in 7TM receptors by protein engineering. Curr. Opin. Biotechnol. 5, 434-444.
23. Strader C. D., Fong T. M., Tota M. R., Underwood D., and Dixon R. A. F. (1994) Structure and function of G protein-coupled receptors. Annu. Rev. Biochem. 63, 101-132.
24. 2 adrenergic receptor increases its affinity for a family of β receptor antagonists. J. Biol. Chem. 266, 15488-15492.
25. 1Dβ. Proc. Natl. Acad. Sci. USA 89, 3630-3634.
26. Wess J., Bonner T. I., and Brann M. R. (1990) Chimeric m2/m3 muscarinic receptors: role of carboxyl terminal receptor domains in selectivity of ligand binding and coupling to phosphoinositide hydrolysis. Mol. Pharmacol. 38, 872-877.
27. Wess J., Gdula D., and Brann M. R. (1992) Structural basis of the subtype selectivity of muscarinic antagonists: a study with chimeric m2/m5 muscarinic receptors. Mol. Pharmacol. 41, 369-374.
28. 5B receptor. FEBS Lett. 333, 25-31.
29. 1E receptor. Mol. Pharmacol. 42, 180-185.